butylscopolammonium bromide has been researched along with mizolastine in 1 studies
| Studies (butylscopolammonium bromide) | Trials (butylscopolammonium bromide) | Recent Studies (post-2010) (butylscopolammonium bromide) | Studies (mizolastine) | Trials (mizolastine) | Recent Studies (post-2010) (mizolastine) |
|---|---|---|---|---|---|
| 695 | 165 | 149 | 108 | 43 | 16 |
| Protein | Taxonomy | butylscopolammonium bromide (IC50) | mizolastine (IC50) |
|---|---|---|---|
| D | Rattus norvegicus (Norway rat) | 0.3548 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.3548 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.3548 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.3548 | |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.3548 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.4058 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berlin, I; Danjou, P; Molinier, P; Morselli, PL; Patat, A; Rosenzweig, P | 1 |
1 trial(s) available for butylscopolammonium bromide and mizolastine
| Article | Year |
|---|---|
Assessment of the anticholinergic effect of the new antihistamine mizolastine in healthy subjects.
Topics: Adult; Benzimidazoles; Butylscopolammonium Bromide; Double-Blind Method; Histamine H1 Antagonists; Humans; Male; Parasympathetic Nervous System | 1992 |